InfuSystem offers an underappreciated clinical-services re-rating story: a dominant outpatient oncology platform, expanding wound-care growth engine, improving margins, conservative leverage, insider buying, and a discounted valuation create asymmetric upside if execution remains on track.
Overview
InfuSystem is a North American healthcare services company specializing in clinic-to-home management of medical devices, clinical support, logistics, and complex reimbursement billing. Roughly 60% of revenue comes from higher-margin Patient Services, led by ambulatory oncology infusion, while 40% comes from Device Solutions, including equipment leasing, disposables, and biomedical services. The company differentiates itself from equipment-only vendors by providing a turnkey platform: home delivery, nursing support, pump tracking, sterilization, payer billing, and provider workflow integration.